-- Target Hospitality (TH) 週二宣布,其售股股東已確定以每股 14 美元的價格發行 700 萬股股票,總募資額約為 9800 萬美元。 承銷商已獲得 30 天的超額配售選擇權,可額外購買至多約 110 萬股股票。 此次發行將於週四結束。 該公司股價在周三盤前交易中下跌超過 10%。
Price: $14.26, Change: $-1.64, Percent Change: -10.31%
-- Target Hospitality (TH) 週二宣布,其售股股東已確定以每股 14 美元的價格發行 700 萬股股票,總募資額約為 9800 萬美元。 承銷商已獲得 30 天的超額配售選擇權,可額外購買至多約 110 萬股股票。 此次發行將於週四結束。 該公司股價在周三盤前交易中下跌超過 10%。
Price: $14.26, Change: $-1.64, Percent Change: -10.31%
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.